AutoICD API

88862-8

Clinical

Hematopoietic stem cell transplantation risk score interpretation EBMT

Definition

This term represents the European Group for Blood and Marrow Transplantation (EBMT) cumulative hematopoietic stem cell transplantation (HSCT) risk score interpretation based on the following factors: the age of the patient, the stage of disease, the time from diagnosis, the donor type, and the donor recipient gender combination. The scores for the individual factors are added together to determine the overall likelihood of success of an HSCT. One study used the EBMT score interpretations and found the following 5-year survival rates: low risk patients had a 50% 5-year survival rate; intermediate risk patients had a 41% 5-year survival rate; poor risk patients had a 31% 5-year survival rate.[http://www.bloodjournal.org/content/126/23/3223]

LOINC 6-Axis Classification

Component

Hematopoietic stem cell transplantation risk score interpretation

Property

Imp

Time Aspect

Pt

System

^Patient

Scale Type

Ord

Method Type

EBMT

Details

Class

CLIN.RISK

Order/Observation

Observation

Short Name

HSCT risk score interp EBMT

Related Names

CLINCLIN.RISKHSCT risk scoreHSCT risk score interpImpressionImpression/interpretation of studyImpressionsInterpInterpretInterpretationInterptIntrpOrdinalPoint in timeQLQualQualitativeRandomScreen

Frequently Asked Questions

What is LOINC code 88862-8?

LOINC code 88862-8 identifies "Hematopoietic stem cell transplantation risk score interpretation EBMT". This term represents the European Group for Blood and Marrow Transplantation (EBMT) cumulative hematopoietic stem cell transplantation (HSCT) risk score interpretation based on the following factors: the age of the patient, the stage of disease, the time from diagnosis, the donor type, and the donor recipient gender combination. The scores for the individual factors are added together to determine the overall likelihood of success of an HSCT. One study used the EBMT score interpretations and found the following 5-year survival rates: low risk patients had a 50% 5-year survival rate; intermediate risk patients had a 41% 5-year survival rate; poor risk patients had a 31% 5-year survival rate.[http://www.bloodjournal.org/content/126/23/3223]

What does 88862-8 measure?

This code measures Hematopoietic stem cell transplantation risk score interpretation in ^Patient. It belongs to the CLIN.RISK class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.